EFNA1 conferred resistance to photofrin-mediated photodynamic therapy resistance in ESCC cells, and EPHA2, which was hyperphosphorylated in ESCC, promoted tumour cell proliferation, migration, invasion and epithelial–mesenchymal transition15,16,35. The gene discussed is EPHA2; the disease is neoplasm.